Therapy News and Research

RSS

Augmentation therapy can save lives of people with alpha-1 antitrypsin deficiency, study shows

Boosting levels of a deficient protein has clear survival benefits for people with the genetic condition alpha-1 antitrypsin deficiency (AATD), according to new research led by RCSI University of Medicine and Health Sciences.

1 Nov 2023

Organon and Sempre Health announce collaboration on new service to help eligible patients save money and stay on their medication as prescribed

Organon (NYSE:OGN) and Sempre Health today announced a strategic partnership designed to motivate eligible patients to refill their prescriptions on time and improve adherence through an innovative pricing program that offers personalized support.

From Organon 1 Nov 2023

Expert consensus on the classification of acute atherothrombotic myocardial infarction by stage of tissue injury severity

A document published in the Canadian Journal of Cardiology outlines the Canadian Cardiovascular Society's classification of acute MI.

1 Nov 2023

Proof-of-concept study holds promise for safer gene therapy techniques for treating immunodeficiencies

Researchers described an approach to edit the recombination-activating gene 2 (RAG2) locus for therapeutic applications.

1 Nov 2023

Managing menopause: The 2023 toolkit for healthcare practitioners

The authors of the revised 2023 Toolkit extracted key recommendations from professional guidelines and positions as well as consensus statements on menopause and related conditions that have emerged since 2014.

1 Nov 2023

Medical school on Cherokee reservation will soon send doctors to tribal, rural areas

Ashton Glover Gatewood decided to give medical school a second try after learning about a new campus designed for Indigenous students like herself.

1 Nov 2023

From Cells to Drugs: How Cell Painting is Transforming Drug Discovery

In this interview, Jordi Carreras delves into the fascinating world of Cell Painting, a powerful technology gaining momentum in drug discovery. He shares insights into his groundbreaking research, the unique aspects of Phenaros' drug discovery platform, and the synergy between academia and industry.

From ELRIG (UK) Ltd. 1 Nov 2023

Researchers harness a combination of lab-grown cells to regenerate damaged heart muscle

Researchers at the University of Wisconsin–Madison and Academia Sinica of Taiwan have harnessed a combination of lab-grown cells to regenerate damaged heart muscle.

31 Oct 2023

A four-stage classification of heart attack based on heart muscle damage

Heart attacks, or acute myocardial infarction (MI), are one of the leading causes of death worldwide. The newly released Canadian Cardiovascular Society Classification of Acute Myocardial Infarction (CCS-AMI) appearing in the Canadian Journal of Cardiology, published by Elsevier, presents a four-stage classification of heart attack based on heart muscle damage.

31 Oct 2023

Trastuzumab deruxtecan offers added benefit for patients with HER2-low breast cancer

The antibody-drug conjugate trastuzumab deruxtecan is approved for various therapeutic indications. Since March 2023, it can also be used as monotherapy for the treatment of adults with unresectable or metastatic HER2-low breast cancer who have received prior chemotherapy at this disease stage or developed disease recurrence early after adjuvant chemotherapy.

31 Oct 2023

Mechanical thrombectomy found to be effective for high-risk pulmonary embolism

New research from the FLASH registry (ClinicalTrials.gov identifier: NCT03761173) shines a light on the effectiveness of large-bore mechanical thrombectomy in managing high-risk pulmonary embolism.

31 Oct 2023

Sickle cell disease patients willing to accept high risks for gene therapy cure

Individuals living with severe sickle cell disease (SCD) are highly interested in new, potentially curative gene therapy treatments and are willing to accept associated risks for a chance at a cure, according to a study published today in Blood Advances.

31 Oct 2023

Using synthetic biology to develop smarter cell therapies for cancer patients

We are embarking on an unprecedented era of therapeutic development enabled by live cell engineering.

31 Oct 2023

Understanding COVID-19 mortality in people with severe mental illness and different ethnicities

In a recent study published in the British Journal of Psychiatry, researchers evaluated mortality in individuals with severe mental illness (SMI) following COVID-19.

31 Oct 2023

University of Melbourne students develop customized video game controller for kid with cerebral palsy

Jerome, a seven-year-old boy with cerebral palsy (CP), has been able to play a video game for the first time, with the help of a team of University of Melbourne Biomedical Engineering Masters students, who have co-designed a customised video game controller with him.

31 Oct 2023

UniSA seeks public support for vital research on deadly brain cancers

The University of South Australia is seeking public support for vital brain cancer research that could potentially save hundreds of lives.

31 Oct 2023

University of Cincinnati to lead NIH StrokeNet for next five years

The University of Cincinnati and UC Health have been renewed as the National Coordinating Center of the National Institutes of Health (NIH) StrokeNet, which is the primary infrastructure for multicenter trials of stroke funded by NIH and the pipeline for new potential treatments for adults and children with stroke and those at risk for stroke.

30 Oct 2023

Scientists identify mechanism of alcohol withdrawal headaches

About 283 million people worldwide suffer from alcohol use disorder, a debilitating health challenge for which limited therapeutic options are available. The cost to society is estimated at greater than $2 trillion annually.

30 Oct 2023

Canadian Cardiovascular Society releases new heart attack classification based on heart tissue damage

The Canadian Cardiovascular Society (CCS) released the world's first classification of acute myocardial infarction (AMI), or heart attack, based on heart tissue damage research that was driven by two cardiovascular investigators within the Ischemic Heart Disease Program of Krannert Cardiovascular Research Center (KCVRC) at Indiana University School of Medicine and Northern Ontario School of Medicine.

30 Oct 2023

Study unveils new approach to more precise, long-lasting, and less toxic cancer treatment

For too long, cancer treatment has been a double-edged sword – the very treatments designed to kill cancer cells often wrought havoc on healthy ones too.

30 Oct 2023

Therapy News and Research

Augmentation therapy can save lives of people with alpha-1 antitrypsin deficiency, study shows

Organon and Sempre Health announce collaboration on new service to help eligible patients save money and stay on their medication as prescribed

Expert consensus on the classification of acute atherothrombotic myocardial infarction by stage of tissue injury severity

Proof-of-concept study holds promise for safer gene therapy techniques for treating immunodeficiencies

Managing menopause: The 2023 toolkit for healthcare practitioners

Medical school on Cherokee reservation will soon send doctors to tribal, rural areas

From Cells to Drugs: How Cell Painting is Transforming Drug Discovery

Researchers harness a combination of lab-grown cells to regenerate damaged heart muscle

A four-stage classification of heart attack based on heart muscle damage

Trastuzumab deruxtecan offers added benefit for patients with HER2-low breast cancer

Mechanical thrombectomy found to be effective for high-risk pulmonary embolism

Sickle cell disease patients willing to accept high risks for gene therapy cure

Using synthetic biology to develop smarter cell therapies for cancer patients

Understanding COVID-19 mortality in people with severe mental illness and different ethnicities

University of Melbourne students develop customized video game controller for kid with cerebral palsy

UniSA seeks public support for vital research on deadly brain cancers

University of Cincinnati to lead NIH StrokeNet for next five years

Scientists identify mechanism of alcohol withdrawal headaches

Canadian Cardiovascular Society releases new heart attack classification based on heart tissue damage

Study unveils new approach to more precise, long-lasting, and less toxic cancer treatment

Industry Focus eBook - Cell biology (5th edition) eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News